Veracyte reported $17.47M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Agenus AGEN:US $ 667K 438K
Agilent A:US $ 734M 26M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
Biocept BIOC:US $ 7.46M 1.54M
Bruker BRKR:US $ 290.2M 14.2M
Exact Sciences EXAS:US $ 113.97M 3.98M
Genmark Diagnostics GNMK:US $ 30.68M 4.58M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Illumina ILMN:US $ 324M 5M
Intrexon XON:US $ 15.03M 2.06M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Laboratory Of America LH:US $ 2575.9M 13.4M
Ligand Pharmaceuticals LGND:US $ 30.59M 22.44M
Luminex LMNX:US $ 44.23M 2.72M
Myriad Genetics MYGN:US $ 53.7M 3.4M
Rigel Pharmaceuticals RIGL:US $ 0.13M 0.19M
Siemens SIE:GR € 10213M 787M
Sonic Healthcare SHL:AU $ 786.14M 44.56M
Thermo Fisher Scientific TMO:US $ 4585M 112M
Veracyte VCYT:US $ 17.47M 5.07M
Waters WAT:US $ 280.25M 26.11M